379. This Month in MedTech 2026: Cardiovascular M&A, Medtronic’s $100M Bet, and the Platform Wars by State of Medtech (opens in new tab)

In this episode of This Month in MedTech 2026, April brings a sharper look at where the market is heading.The discussion covers Medtronic’s $100M investment in Pulnovo, why denervation may be turning into a platform strategy, and how China market access could become a bigger part of global MedTech dealmaking. The episode also unpacks Q1 funding trends, cardiovascular M&A, and key deals across thrombectomy, oncology, metabolic disease, lung cancer, and wearable robotics. The bigger message is ...